First live birth after ovarian stimulation using a chimeric long-acting human recombinant follicle-stimulating hormone (FSH) agonist (recFSH-CTP) for in vitro fertilization

Fertility and Sterility

Volumn 79, Issue 3, 2003, Pages 621-623

  Beckers, Nicole G M ^a   Macklon, Nicholas S ^a   Devroey, Paul ^b   Platteau, Peter ^b   Boerrigter, Peter J ^c   Fauser, Bart C J M ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b CENTRE FOR REPRODUCTIVE MEDICINE   (Belgium)

^c NV ORGANON   (Netherlands)

Author keywords

COH; IVF; Ovarian stimulation; Pregnancy; recFSH CTP; Recombinant FSH

Indexed keywords

CHORIONIC GONADOTROPIN; CORIFOLLITROPIN ALPHA; GANIRELIX; GONADORELIN ANTAGONIST; LONG ACTING DRUG; LUTEINIZING HORMONE; RECOMBINANT FOLLITROPIN; RECOMBINANT HORMONE; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BIRTH; CASE REPORT; CELL CULTURE; CELL STIMULATION; EMBRYO TRANSFER; FEMALE; FEMALE INFERTILITY; FERTILIZATION; FERTILIZATION IN VITRO; HEALTH CENTER; HUMAN; INTRACYTOPLASMIC SPERM INJECTION; OOCYTE; OOCYTE MATURATION; PREGNANCY; PREGNANCY TEST; PRIMIGRAVIDA; PRIORITY JOURNAL; TREATMENT FAILURE; TREATMENT OUTCOME; ULTRASOUND; UTERUS;

EID: 0037338177     PISSN: 00150282     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0015-0282(02)04804-5     Document Type: Article

References (15)

1. Pierce J.G., Parsons T.F. Glycoprotein hormones structure and function . Annu Rev Biochem. 50:1981;465-495.
2. Fiddes J.C., Goodman H.M. The cDNA for the beta-subunit of human chorionic gonadotropin suggests evolution of a gene by readthrough into the 3'-untranslated region. Nature. 286:1980;684-687.
3. Keutmann H.T., Charlesworth M.C., Mason K.A., Ostrea T., Johnson L., Ryan R.J. A receptor-binding region in human choriogonadotropin/lutropin beta subunit. Proc Natl Acad Sci USA. 84:1987;2038-2042.
4. Damewood M.D., Shen W., Zacur H.A., Schlaff W.D., Rock J.A., Wallach E.E. Disappearance of exogenously administered human chorionic gonadotropin. Fertil Steril. 52:1989;398-400.
5. Fauser B.C., Van Heusden A.M. Manipulation of human ovarian function physiological concepts and clinical consequences . Endocrinol Rev. 18:1997;71-106.
6. Keene J.L., Matzuk M.M., Otani T., Fauser B.C., Galway A.B., Hsueh A.J., et al. Expression of biologically active human follitropin in Chinese hamster ovary cells. J Biol Chem. 264:1989;4769-4775.
7. Recombinant follicle stimulating hormone development of the first biotechnology product for the treatment of infertility . Hum Reprod Update. 4:1998;862-881.
8. Donderwinkel P.F., Schoot D.C., Coelingh Bennink H.J., Fauser B.C. Pregnancy after induction of ovulation with recombinant human FSH in polycystic ovary syndrome. Lancet. 340:1992;983.
9. Devroey P., Van Steirteghem A., Mannaerts B., Coelingh B.H. First singleton term birth after ovarian superovulation with rhFSH. Lancet. 340:1992;1108-1109.
10. Mannaerts B., Shoham Z., Schoot D., Bouchard P., Harlin J., Fauser B., et al. Single-dose pharmacokinetics and pharmacodynamics of recombinant human follicle-stimulating hormone (Org 32489*) in gonadotropin-deficient volunteers. Fertil Steril. 59:1993;108-114.
11. Fares F.A., Suganuma N., Nishimori K., LaPolt P.S., Hsueh A.J., Boime I. Design of a long-acting follitropin agonist by fusing the C-terminal sequence of the chorionic gonadotropin beta subunit to the follitropin beta subunit. Proc Natl Acad Sci USA. 89:1992;4304-4308.
12. Bouloux P.M., Handelsman D.J., Jockenhovel F., Nieschlag E., Rabinovici J., Frasa W.L., et al. First human exposure to FSH-CTP in hypogonadotrophic hypogonadal males. Hum Reprod. 16:2001;1592-1597.
13. Duijkers JM, Klipping C, Boerrigter PJ, Machielsen CSM, de Bie JJ, Voortman G. Single dose pharmacokinetics and effect on follicular growth and serum hormones of a long-acting recombinant FSH preparation (FSH-CTP) in healthy pituitary suppressed females. Hum Reprod 2002;17:1987-93.
14. Devroey P., Mannaerts B., Smitz J., Coelingh B.H., Van Steirteghem A. Clinical outcome of a pilot efficacy study on recombinant human follicle-stimulating hormone (Org 32489) combined with various gonadotrophin-releasing hormone agonist regimens. Hum Reprod. 9:1994;1064-1069.
15. de Jong D., Macklon N.S., Eijkemans M.J., Mannaerts B.M., Coelingh Bennink H.J., Fauser B.C. Dynamics of the development of multiple follicles during ovarian stimulation for in vitro fertilization using recombinant follicle-stimulating hormone (Puregon) and various doses of the gonadotropin-releasing hormone antagonist ganirelix (Orgalutran/Antagon). Fertil Steril. 75:2001;688-693.